Form 4 for ACXP Acurx Pharmaceuticals, Inc.
Accepted 2021-09-10 00:00:00 ET · period of report 2021-06-29 · accession 0001104659-21-114674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-10 | 2021-06-29 | ACXP | Sailer Carl | Dir | P - Purchase | $6.00 | +12.5K | 67.9K | +23% | +$75.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-29 | P | A | 12,500 | $6.00 | 67,917 | D | — | — | (F1) Represents shares of common stock of Acurx Pharmaceuticals, Inc. (the "Issuer") purchased by the reporting person in connection with the Issuer's initial public offering, which closed on June 29, 2021. Due to an unintentional oversight, the transaction reported on this Form 4 was not previously filed on a Form 4 in a timely manner and was omitted from one Form 4 that was subsequently filed. The 12,500 shares of common stock of the Issuer were purchased at the initial public offering price of $6.00 per share. |